Cargando…

A Patients-Based Statistical Model of Radiotherapy Dose Distribution in Nasopharyngeal Cancer

PURPOSE: To develop a patients-based statistical model of dose distribution among patients with nasopharyngeal cancer (NPC). METHODS AND MATERIALS: The dose distributions of 75 patients with NPC were acquired and preprocessed to generate a dose-template library. Subsequently, the dominant modes of d...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Gang, Yang, Jing, Nie, Xin, Zhu, Xiaohui, Li, Xiaoqiang, zhou, Jun, Kabolizadeh, Peyman, Li, Qin, Quan, Hong, Ding, Xuanfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913054/
https://www.ncbi.nlm.nih.gov/pubmed/31857802
http://dx.doi.org/10.1177/1559325819892359
_version_ 1783479596717441024
author Liu, Gang
Yang, Jing
Nie, Xin
Zhu, Xiaohui
Li, Xiaoqiang
zhou, Jun
Kabolizadeh, Peyman
Li, Qin
Quan, Hong
Ding, Xuanfeng
author_facet Liu, Gang
Yang, Jing
Nie, Xin
Zhu, Xiaohui
Li, Xiaoqiang
zhou, Jun
Kabolizadeh, Peyman
Li, Qin
Quan, Hong
Ding, Xuanfeng
author_sort Liu, Gang
collection PubMed
description PURPOSE: To develop a patients-based statistical model of dose distribution among patients with nasopharyngeal cancer (NPC). METHODS AND MATERIALS: The dose distributions of 75 patients with NPC were acquired and preprocessed to generate a dose-template library. Subsequently, the dominant modes of dose distribution were extracted using principal component analysis (PCA). Leave-one-out cross-validation (LOOCV) was performed for evaluation. Residual reconstruction errors between the doses reconstructed using different dominating eigenvectors and the planned dose distribution were calculated to investigate the convergence characteristics. Three-dimensional Gamma analysis was performed to investigate the accuracy of dose reconstruction. RESULTS: The first 29 components contained 90% of the variance in dose distribution, and 45 components accounted for more than 95% of the variance on average. The residual error of the LOOCV model for the cumulative sum of components over all patients decreased from 8.16 to 4.79 Gy when 1 to 74 components were included in the LOOCV model. The 3-dimensional Gamma analysis results implied that the PCA model was capable of dose distribution reconstruction, and the accuracy was especially satisfactory in the high-dose area. CONCLUSIONS: A PCA-based model of dose distribution variations in patients with NPC was developed, and its accuracy was determined. This model could serve as a predictor of 3-dimensional dose distribution.
format Online
Article
Text
id pubmed-6913054
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-69130542019-12-19 A Patients-Based Statistical Model of Radiotherapy Dose Distribution in Nasopharyngeal Cancer Liu, Gang Yang, Jing Nie, Xin Zhu, Xiaohui Li, Xiaoqiang zhou, Jun Kabolizadeh, Peyman Li, Qin Quan, Hong Ding, Xuanfeng Dose Response Original Article PURPOSE: To develop a patients-based statistical model of dose distribution among patients with nasopharyngeal cancer (NPC). METHODS AND MATERIALS: The dose distributions of 75 patients with NPC were acquired and preprocessed to generate a dose-template library. Subsequently, the dominant modes of dose distribution were extracted using principal component analysis (PCA). Leave-one-out cross-validation (LOOCV) was performed for evaluation. Residual reconstruction errors between the doses reconstructed using different dominating eigenvectors and the planned dose distribution were calculated to investigate the convergence characteristics. Three-dimensional Gamma analysis was performed to investigate the accuracy of dose reconstruction. RESULTS: The first 29 components contained 90% of the variance in dose distribution, and 45 components accounted for more than 95% of the variance on average. The residual error of the LOOCV model for the cumulative sum of components over all patients decreased from 8.16 to 4.79 Gy when 1 to 74 components were included in the LOOCV model. The 3-dimensional Gamma analysis results implied that the PCA model was capable of dose distribution reconstruction, and the accuracy was especially satisfactory in the high-dose area. CONCLUSIONS: A PCA-based model of dose distribution variations in patients with NPC was developed, and its accuracy was determined. This model could serve as a predictor of 3-dimensional dose distribution. SAGE Publications 2019-12-13 /pmc/articles/PMC6913054/ /pubmed/31857802 http://dx.doi.org/10.1177/1559325819892359 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Liu, Gang
Yang, Jing
Nie, Xin
Zhu, Xiaohui
Li, Xiaoqiang
zhou, Jun
Kabolizadeh, Peyman
Li, Qin
Quan, Hong
Ding, Xuanfeng
A Patients-Based Statistical Model of Radiotherapy Dose Distribution in Nasopharyngeal Cancer
title A Patients-Based Statistical Model of Radiotherapy Dose Distribution in Nasopharyngeal Cancer
title_full A Patients-Based Statistical Model of Radiotherapy Dose Distribution in Nasopharyngeal Cancer
title_fullStr A Patients-Based Statistical Model of Radiotherapy Dose Distribution in Nasopharyngeal Cancer
title_full_unstemmed A Patients-Based Statistical Model of Radiotherapy Dose Distribution in Nasopharyngeal Cancer
title_short A Patients-Based Statistical Model of Radiotherapy Dose Distribution in Nasopharyngeal Cancer
title_sort patients-based statistical model of radiotherapy dose distribution in nasopharyngeal cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913054/
https://www.ncbi.nlm.nih.gov/pubmed/31857802
http://dx.doi.org/10.1177/1559325819892359
work_keys_str_mv AT liugang apatientsbasedstatisticalmodelofradiotherapydosedistributioninnasopharyngealcancer
AT yangjing apatientsbasedstatisticalmodelofradiotherapydosedistributioninnasopharyngealcancer
AT niexin apatientsbasedstatisticalmodelofradiotherapydosedistributioninnasopharyngealcancer
AT zhuxiaohui apatientsbasedstatisticalmodelofradiotherapydosedistributioninnasopharyngealcancer
AT lixiaoqiang apatientsbasedstatisticalmodelofradiotherapydosedistributioninnasopharyngealcancer
AT zhoujun apatientsbasedstatisticalmodelofradiotherapydosedistributioninnasopharyngealcancer
AT kabolizadehpeyman apatientsbasedstatisticalmodelofradiotherapydosedistributioninnasopharyngealcancer
AT liqin apatientsbasedstatisticalmodelofradiotherapydosedistributioninnasopharyngealcancer
AT quanhong apatientsbasedstatisticalmodelofradiotherapydosedistributioninnasopharyngealcancer
AT dingxuanfeng apatientsbasedstatisticalmodelofradiotherapydosedistributioninnasopharyngealcancer
AT liugang patientsbasedstatisticalmodelofradiotherapydosedistributioninnasopharyngealcancer
AT yangjing patientsbasedstatisticalmodelofradiotherapydosedistributioninnasopharyngealcancer
AT niexin patientsbasedstatisticalmodelofradiotherapydosedistributioninnasopharyngealcancer
AT zhuxiaohui patientsbasedstatisticalmodelofradiotherapydosedistributioninnasopharyngealcancer
AT lixiaoqiang patientsbasedstatisticalmodelofradiotherapydosedistributioninnasopharyngealcancer
AT zhoujun patientsbasedstatisticalmodelofradiotherapydosedistributioninnasopharyngealcancer
AT kabolizadehpeyman patientsbasedstatisticalmodelofradiotherapydosedistributioninnasopharyngealcancer
AT liqin patientsbasedstatisticalmodelofradiotherapydosedistributioninnasopharyngealcancer
AT quanhong patientsbasedstatisticalmodelofradiotherapydosedistributioninnasopharyngealcancer
AT dingxuanfeng patientsbasedstatisticalmodelofradiotherapydosedistributioninnasopharyngealcancer